New Allergy Drug Gets Preliminary FDA Approval

Monday, 09 Dec 2013 04:10 PM

 

Share:
  Comment  |
   Contact Us  |
  Print  
|  A   A  
  Copy Shortlink
An oral immunotherapy aimed at grass and pollen allergies has a benefit and safety profile that supports its approval, according to briefing documents posted on Monday by the U.S. Food and Drug Administration ahead of a meeting by outside experts to discuss the drug.

Oralair, made by France's Stallergenes SA, would be the first such licensed therapy in the United States. It has been in use in Europe for several years.

The documents were posted prior to a meeting on Wednesday of an FDA advisory committee meeting that will provide a recommendation on whether the drug merits U.S. approval. The FDA considers advisory panel views when it decides whether to approve a drug, but is not obligated to follow its recommendation.

The FDA committee documents said that several large studies in Europe and the United States showed that the drug's efficacy was "robust" and "consistent." The documents said the treatment was "generally well-tolerated."

On Thursday, the committee will meet to discuss Grastek, an oral treatment for grass allergies that would be sold by Merck & Co. In Europe, Merck's partner, Danish company ALK Abello, sells the product as Grazax.

© 2014 Thomson/Reuters. All rights reserved.

Share:
  Comment  |
   Contact Us  |
  Print  
  Copy Shortlink
Around the Web
Comments
Please review Community Guidelines before posting a comment.
>> Register to share your comments with the community.
>> Login if you are already a member.
blog comments powered by Disqus
 
Email:
Country
Zip Code:
Privacy: We never share your email.
 
Find Your Condition
You May Also Like
Around the Web
Most Commented

The information presented on this website is not intended as specific medical advice and is not a substitute for professional medical treatment or diagnosis. Read Newsmax Terms and Conditions of Service.

Newsmax, Moneynews, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, NewsmaxWorld, NewsmaxHealth, are trademarks of Newsmax Media, Inc.

NEWSMAXHEALTH.COM
© Newsmax Media, Inc.
All Rights Reserved